1. Home
  2. news
  3. Business

CDK4/6 Inhibition With Palbociclib Displays Activity in Low-Grade Serous Ovarian Cancer

5 months ago | By: OncLive
CDK4/6 Inhibition With Palbociclib Displays Activity in Low-Grade Serous Ovarian Cancer
description

Palbociclib (Ibrance) monotherapy displayed modest activity for the treatment of unselected patients with ovarian cancer. Nevertheless, treatment with a CDk4/6 inhibitor showed promising efficacy in patients with low-grade serous ovarian cancer (LGSO... [5272 chars].. reed more

(6)preview (5)click

Post your Blog Click here

Category

General

World

Nation

Business

Technology

Entertainment

Sports

Science

Health

Recent news
Power the AI-first retail revolution with Lenovo's Solutions & Services Group

Power the AI-first retail revolution with Lenovo's Solutions & Services Group

12 hours ago
Benjani Mwaruwari on cloud nine after maintaining Highlanders' unbeaten run against Dynamos

Benjani Mwaruwari on cloud nine after maintaining Highlanders' unbeaten run against Dynamos

12 hours ago
OnePlus Nord 6 Tipped to Have Same Specifications as China-exclusive OnePlus Turbo 6; May Launch in April

OnePlus Nord 6 Tipped to Have Same Specifications as China-exclusive OnePlus Turbo 6; May Launch in April

12 hours ago
Sudden Sight Loss Risk Almost 5x Higher With Wegovy Than Ozempic, Study Finds

Sudden Sight Loss Risk Almost 5x Higher With Wegovy Than Ozempic, Study Finds

12 hours ago
Severe flooding kills 66 in Kenya, as heavy rains continue

Severe flooding kills 66 in Kenya, as heavy rains continue

13 hours ago
Trump's ill-fated attempt to copy Israel's 'mowing the grass' strategy

Trump's ill-fated attempt to copy Israel's 'mowing the grass' strategy

13 hours ago